Bispecific Antibody

COPENHAGEN, Denmark, June 29, 2026 Genmab A/S announced positive topline results from the Phase 3 EPCORE DLBCL-4 clinical trial...

LAUSANNE, Switzerland, June 30, 2026 ADC Therapeutics SA has announced the successful completion of patient enrollment in the LOTIS-7...

SHANGHAI, June 23, 2026 Mabwell announced that China’s National Medical Products Administration (NMPA) has granted Investigational New Drug (IND)...

SHANGHAI, China, June 22, 2026 CureGene Pharmaceutical has announced the successful dosing of the first participant in the U.S....

BOSTON, Singapore and Hong Kong, June 22, 2026 Antengene Corporation Limited has announced a landmark strategic licensing agreement with...

PRINCETON, N.J., June 17, 2026 Bristol Myers Squibb (BMS) has announced that its Board of Directors has declared a...

WATERTOWN, Mass., June 17, 2026 Triveni Bio, a clinical-stage biotechnology company developing innovative antibody therapies for immunological and inflammatory...

HONG KONG, June 15, 2026 Akeso, Inc. has announced the enrollment of the first patient in the Phase Ib/II...

BOSTON, June 15, 2026 Bambusa Therapeutics has announced positive preliminary results from the multiple ascending dose (MAD) cohorts of...

SHANGHAI and HONG KONG, China, June 10, 2026 Antengene announced that China’s National Medical Products Administration (NMPA) has approved...